TSX:TGOD

Stock Analysis Report

Green Organic Dutchman Holdings

Executive Summary

The Green Organic Dutchman Holdings Ltd., through its subsidiary, The Green Organic Dutchman Ltd., operates as a cannabinoid-based research and development company in Canada.

Snowflake

Fundamentals

Mediocre balance sheet with limited growth.


Similar Companies

Share Price & News

How has Green Organic Dutchman Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-13.5%

TGOD

2.6%

CA Pharmaceuticals

-0.2%

CA Market


1 Year Return

-71.4%

TGOD

-50.2%

CA Pharmaceuticals

1.5%

CA Market

Return vs Industry: TGOD underperformed the Canadian Pharmaceuticals industry which returned -50.2% over the past year.

Return vs Market: TGOD underperformed the Canadian Market which returned 1.5% over the past year.


Shareholder returns

TGODIndustryMarket
7 Day-13.5%2.6%-0.2%
30 Day-57.2%-20.3%-3.5%
90 Day-60.3%-32.5%-1.8%
1 Year-71.4%-71.4%-50.2%-50.2%5.1%1.5%
3 Yearn/a78.2%76.8%13.3%3.2%
5 Yearn/a285.7%285.7%25.2%7.2%

Price Volatility Vs. Market

How volatile is Green Organic Dutchman Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Green Organic Dutchman Holdings undervalued compared to its fair value and its price relative to the market?

0.79x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate TGOD's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate TGOD's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: TGOD is unprofitable, so we can't compare its PE Ratio to the Pharmaceuticals industry average.

PE vs Market: TGOD is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate TGOD's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: TGOD is good value based on its PB Ratio (0.8x) compared to the CA Pharmaceuticals industry average (1.9x).


Next Steps

Future Growth

How is Green Organic Dutchman Holdings forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

98.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: TGOD is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: TGOD is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: TGOD is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: TGOD's revenue (112% per year) is forecast to grow faster than the Canadian market (5.7% per year).

High Growth Revenue: TGOD's revenue (112% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if TGOD's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Green Organic Dutchman Holdings performed over the past 5 years?

-144.3%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: TGOD is unprofitable, and there is insufficient past data to establish if their past 5-year earnings growth rate was positive.

Accelerating Growth: Unable to compare TGOD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TGOD is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (15.6%).


Return on Equity

High ROE: TGOD has a negative Return on Equity (-15%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: TGOD is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: TGOD is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Green Organic Dutchman Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: TGOD's short term assets (CA$151.4M) exceeds its short term liabilities (CA$32.5M)

Long Term Liabilities: TGOD's short term assets (151.4M) exceeds its long term liabilities (3.2M)


Debt to Equity History and Analysis

Debt Level: TGOD's debt to equity ratio (0.1%) is considered satisfactory

Reducing Debt: Insufficient data to determine if TGOD's debt to equity ratio has reduced over the past 5 years.


Balance Sheet

Inventory Level: TGOD has a high level of physical assets or inventory.

Debt Coverage by Assets: TGOD's debt is covered by short term assets (assets are 284.546990x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TGOD has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: TGOD has less than a year of cash runway if free cash flow continues to reduce at historical rates of -106% each year


Next Steps

Dividend

What is Green Organic Dutchman Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.0%markettop25%6.0%industryaverage2.8%forecastin3Years0%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate TGOD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate TGOD's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if TGOD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if TGOD's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of TGOD's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

What is the CEO of Green Organic Dutchman Holdings's salary, the management and board of directors tenure and is there insider trading?

1.1yrs

Average management tenure


CEO

Brian Athaide (50yo)

1.3yrs

Tenure

CA$3,813,393

Compensation

Mr. Brian D. Athaide has been Chief Executive Officer of The Green Organic Dutchman Holdings Ltd. (TGOD) since July 1, 2018 and has been its Director since September 24, 2018. Mr. Athaide served as Chief F ...


CEO Compensation Analysis

Compensation vs. Market: Insufficient data to establish whether Brian's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Insufficient data to compare Brian's compensation with company performance.


Management Age and Tenure

1.1yrs

Average Tenure

55.5yo

Average Age

Experienced Management: TGOD's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.


Board Age and Tenure

1.1yrs

Average Tenure

53.5yo

Average Age

Experienced Board: TGOD's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

SellCA$86,499,99904 Sep 19
Aurora Cannabis Inc.
EntityCompany
Shares28,833,334
Max PriceCA$3.00
BuyCA$93626 Jun 19
Anna Stewart
EntityIndividual
Role
Chief Legal Officer
General Counsel & Corporate Secretary
Shares300
Max PriceCA$3.12
BuyCA$168,48631 May 19
Brian Athaide
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares43,960
Max PriceCA$3.86
SellCA$658,92729 May 19
Ian Wilms
EntityIndividual
Role
Chief Compliance Officer
Director of Compliance & Government Affairs
Shares162,155
Max PriceCA$4.10
BuyCA$21,95004 Apr 19
Sean Bovingdon
EntityIndividual
Role
Chief Financial Officer
Chief Financial Officer
Shares5,000
Max PriceCA$4.39
SellCA$2,940,06601 Apr 19
Marc Bertrand
EntityIndividual
Role
Member of the Board of Directors
Director
Shares600,000
Max PriceCA$4.91
SellCA$1,013,87626 Mar 19
Ian Wilms
EntityIndividual
Role
Chief Compliance Officer
Director of Compliance & Government Affairs
Shares208,104
Max PriceCA$4.89
SellCA$11,478,48711 Jan 19
Aurora Cannabis Inc.
EntityCompany
Shares4,500,000
Max PriceCA$2.61
BuyCA$18,67504 Jan 19
Sean Bovingdon
EntityIndividual
Role
Chief Financial Officer
Chief Financial Officer
Shares7,500
Max PriceCA$2.49
SellCA$419,53228 Dec 18
Lola Ventures Inc.
EntityCompany
Shares183,000
Max PriceCA$2.32
BuyCA$39,86507 Dec 18
Andrew Pollock
EntityIndividual
Shares13,500
Max PriceCA$2.95
BuyCA$63,00003 Dec 18
Michael Gibbons
EntityIndividual
Role
Head of Sales
Vice President of Sales
Shares20,000
Max PriceCA$3.15
BuyCA$3,21027 Nov 18
Anna Stewart
EntityIndividual
Role
Chief Legal Officer
General Counsel & Corporate Secretary
Shares1,000
Max PriceCA$3.21
SellCA$165,00023 Nov 18
Lola Ventures Inc.
EntityCompany
Shares50,000
Max PriceCA$3.30
BuyCA$336,71520 Nov 18
Brian Athaide
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares106,850
Max PriceCA$3.17
SellCA$1,253,40908 Nov 18
Stephen Dobler
EntityIndividual
Shares280,000
Max PriceCA$4.79
SellCA$497,95008 Nov 18
Lola Ventures Inc.
EntityCompany
Shares115,000
Max PriceCA$4.33

Ownership Breakdown


Management Team

  • Sean Bovingdon

    Chief Financial Officer

    • Tenure: 1yrs
    • Compensation: CA$1.72m
  • Csaba Reider (62yo)

    President

    • Tenure: 2.4yrs
    • Compensation: CA$1.21m
  • Mike Gibbons (60yo)

    Vice President of Sales

    • Tenure: 1.6yrs
    • Compensation: CA$1.27m
  • Rav Kumar

    Chief Science Officer

    • Tenure: 0.8yrs
  • Brian Athaide (50yo)

    CEO & Director

    • Tenure: 1.3yrs
    • Compensation: CA$3.81m
  • Ian Wilms (51yo)

    Director of Compliance & Government Affairs

    • Tenure: 0yrs
    • Compensation: CA$194.26k
  • Anna Stewart

    General Counsel & Corporate Secretary

    • Tenure: 0.8yrs
  • John Wren

    Vice President of Operations

    • Tenure: 0yrs
  • Geoff Riggs

    Chief Information Officer

    • Tenure: 0.8yrs
  • Marie-Josee Lafrance

    Vice President of Human Resources

    • Tenure: 1.3yrs
    • Compensation: CA$1.20m

Board Members

  • Marc Bertrand (51yo)

    Director

    • Tenure: 2.1yrs
    • Compensation: CA$217.53k
  • Jeff Scott (56yo)

    Chairman of the Board

    • Tenure: 1.3yrs
    • Compensation: CA$717.85k
  • Nick Kirton (74yo)

    Director

    • Tenure: 1.8yrs
    • Compensation: CA$630.15k
  • Jacques Dessureault (56yo)

    Director

    • Tenure: 0.8yrs
  • Tim Seymour

    Member of the Advisory Board

    • Tenure: 1.1yrs
  • Brian Athaide (50yo)

    CEO & Director

    • Tenure: 1.3yrs
    • Compensation: CA$3.81m
  • Caroline MacCallum (36yo)

    Director

    • Tenure: 0.8yrs

Company Information

The Green Organic Dutchman Holdings Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: The Green Organic Dutchman Holdings Ltd.
  • Ticker: TGOD
  • Exchange: TSX
  • Founded: 2016
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: CA$316.825m
  • Shares outstanding: 275.50m
  • Website: https://www.tgod.ca

Number of Employees


Location

  • The Green Organic Dutchman Holdings Ltd.
  • Building A
  • Suite 301
  • Mississauga
  • Ontario
  • L4V 1E3
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TGODTSX (The Toronto Stock Exchange)YesCommon SharesCACADMay 2018
TGOD.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDMay 2018
O1GADB (Deutsche Boerse AG)YesCommon SharesDEEURMay 2018

Biography

The Green Organic Dutchman Holdings Ltd., through its subsidiary, The Green Organic Dutchman Ltd., operates as a cannabinoid-based research and development company in Canada. It produces organic cannabis p ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/22 00:36
End of Day Share Price2019/10/21 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.